Team (IMAGE)
Caption
Pictured left to right: Christopher Hulme, graduate assistant Chris Foley, and Travis Dunckley. Hulme and Dunckley's recently-formed company Iluminos has developed compounds that may help treat neurodegenerative diseases like Alzheimer's.
A new study describes a small molecule kinase inhibitor that has shown effectiveness in blocking or delaying the development of plaques and tangles--pathologies caused by accumulations of amyloid and tau proteins in the brain.
Credit
Paul Tumarkin/Tech Launch Arizona
Usage Restrictions
None
License
Licensed content